Evolution of a longitudinal, multidisciplinary, and scalable patient navigation matrix model

Cancer Medicine
Cheyenne M CorbettSteven Patierno

Abstract

This Longitudinal patient navigation Matrix Model was developed to overcome barriers across the cancer care continuum by offering prepatients, patients, and their families with support services. The extraordinary heterogeneity of patient needs during cancer screening, risk assessment, treatment, and survivorship as well as the vast heterogeneity of oncology care settings make it nearly impossible to follow a static navigation model. Our model of patient cancer navigation is unique as it enhances the traditional model by being highly adaptable based on both patient and family needs and scalable based on institutional needs and resources (eg, clinical volumes, financial resources, and community-based resources). This relatively new operational model for system-wide and systematic navigation incorporates a carefully cultivated supportive care program that evolved over the last decade from a bottom up approach that identified patient and family needs and developed appropriate resources. A core component of this model includes shifting away from department-centric operations. This model does not require a patient to opt in or independently be able to report their needs or ask for services-it is an opt out model. The multidisciplinar...Continue Reading

References

Feb 24, 2005·Cancer·Paul B JacobsenJimmie C Holland
Oct 28, 2008·Cancer·Karen M FreundUNKNOWN Patient Navigation Research Program Group
Nov 26, 2008·Journal of the National Medical Association·Chyongchiou J LinDwight E Heron
Jul 1, 2009·Journal of Oncology Practice·Janice Hopkins, Matthew P Mumber
Jun 21, 2011·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Oct 8, 2011·Current Oncology·D Howell, K Olsen
Mar 17, 2012·Journal of Health Care for the Poor and Underserved·Kathryn L BraunAmelie G Ramirez
Oct 10, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Harold P Freeman
Oct 10, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Donald J DudleyAmelie Ramirez
Oct 10, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Tracy A BattagliaKaren M Freund
Oct 10, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Heather J HoffmanSteven R Patierno
Jun 19, 2014·Journal of the National Cancer Institute·Karen M FreundUNKNOWN Writing Group of the Patient Navigation Research Program
Jul 30, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Naomi Y KoTracy A Battaglia
Dec 2, 2015·Journal of Women's Health·Electra D PaskettUNKNOWN PNRP Investigators
Sep 21, 2016·Cancer·Elizabeth M WhitleyUNKNOWN Patient Navigation Research Program Investigators
Nov 24, 2016·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Ajeesh Sunny, Luis Rustveld
Sep 15, 2017·Medical Care·Erin M ColliganAdil Moiduddin

❮ Previous
Next ❯

Citations

Apr 9, 2021·American Society of Clinical Oncology Educational Book·Niharika DixitNancy J Burke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Journal of Oncology Nursing
Anne Willis
CA: a Cancer Journal for Clinicians
Electra D PaskettKristen J Wells
Cancer
Kristen J WellsPatient Navigation Research Program
Seminars in Oncology Nursing
Lillie D ShockneyCynthia Cantril
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Sharon H BaikKristen J Wells
© 2021 Meta ULC. All rights reserved